CURRENT
ISSUE
1528
August 28, 2017
The goal of asthma treatment is to control symptoms and prevent exacerbations. Management of acute exacerbations of asthma is not discussed here....  Continue reading
More from Issue 1528
Previous Issue: 1527      August 14, 2017
Coming Soon
Prasterone (Intrarosa) for Dyspareunia
Safinamide (Xadago) for Adjunctive Treatment of Parkinson's Disease
Insulin Degludec/Liraglutide (Xultophy 100/3.6) for Type 2 Diabetes
Deflazacort (Emflaza) for Duchenne Muscular Dystrophy
Search
Subscribe
Reader Testimonials
Watch the video!
Conversation
Follow us  facebook        Email Alerts
 Tweets
Featured Article
FROM
ISSUE
1527

For many years, the goal of drug therapy for most patients with type 2 diabetes has been to achieve and maintain an A1C of <7%. Achieving that goal can prevent microvascular complications (diabetic retinopathy, nephropathy, neuropathy), but whether it prevents macrovascular complications (myocardial infarction [MI], stroke) has been less clear. The FDA now requires that cardiovascular safety studies be performed for all new drugs for type 2 diabetes.1 Recent findings that some of the newer second-line drugs for type 2 diabetes have cardiovascular benefits have led to new interest in the ... Continue reading